Saturday, 04 December 2021

 

 

LATEST NEWS IND v NZ, 2nd Test : Ajaz Patel claims all-10 wickets, only the third bowler to do so IND vs NZ, 2nd Test: Agarwal's ton pushes India ahead after Ajaz Patel's four-for Junior Men's Hockey WC: Argentina beat France 3-1 to reach final ITF World Women's Tour C'ships: Pranjala Yadlapalli beats Vaidehi to reach semis Junior Men's Hockey WC: India's title defence ends with 2-4 loss against Germany in semis ISL 2021-22: Chennaiyin FC, East Bengal share points after goalless draw 'Bigg Boss 15': Buzz builds up about Shehnaaz Gill's entry into the house Vicky-Katrina wedding: Event-related stickers must on vehicles 120 bigwigs expected for Katrina-Vicky Kaushal's wedding Looking forward to doing one Punjabi film a year : Wamiqa Gabbi Neeraj Chopra compares dancers with athletes on 'Dance + Season 6' IANS Review: 'Tadap': And the fault lies in Ahan Shetty's stars Sara Ali Khan pens heartfelt note for Rohit Shetty, Aanand L Rai Hitesh Bharadwaj, Akshita Mudgal open up on their roles in 'Iss Mod Se Jaate Hain' Contestants undergo tough tasks in 'Bigg Boss Telugu 5' to win 'Ticket To Finale' Looking beyond 'Major', Telugu actor Adivi Sesh eyes Bollywood projects Asha Bhosle calls 'India's Best Dancer 2' contestant 'Chhoti Helen' IANS Review: Good in parts, 'Bachelor' exposes how Domestic Violence Act is misused IANS Review: 'Chithirai Sevvaanam': A grim story that gets you thinking Lt Governor participates in BSF’s 57th Raising Day celebrations Charanjit Singh Channi Assails Captain For Myopic Mindset Towards Weaker Sections

 

Zenara Pharma gets approval to manufacture, sell Favipiravir

Web Admin

Web Admin

5 Dariya News

Hyderabad , 05 Aug 2020

Hyderabad-based Zenara Pharma on Wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of Covid-19.The tablet, which will be sold under the brand name 'Favizen', is being manufactured at Zenara's US FDA approved state-of-the-art facility in Hyderabad.Zenara Pharma, a fully-owned subsidiary of Biophore India Pharmaceuticals, is in talks with multiple state institutions and several hospitals in India to ensure that Favizen is readily available for the patients in need."Given the ongoing pandemic, it has become extremely critical for pharmaceutical companies to quickly provide safe and effective treatment options to the patients with Covid-19. I am proud to say that we have our own in-house API and are not dependent on any imports for the production."We believe that this will ensure stability and rapid production and availability of this treatment for the Indian market. We are also in talks with various institutions to make the tablets available at discounted or no cost to underprivileged patients," said Jagadeesh Babu Rangisetty, Co-founder and Managing Director, Zenara Pharma.The company said that it has the manufacturing and distribution capabilities to improve access to this treatment around the world and has already begun exports to the Middle East and Latin American countries.Favipiravir has demonstrated positive clinical outcomes in some trials and has already been approved for use to treat Covid-19 in Russia and parts of the Middle East. Advance stage trials are currently underway in several countries, including India.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Pandemic , Hyderabad , Zenara Pharma , Favipiravir , Drugs Controller General of India , DCGI

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD